Amgad Saleh

Title: Amgad Saleh: Innovator in Neuropsychiatric Treatments

Introduction

Amgad Saleh is a notable inventor based in Dayton, NJ (US), recognized for his contributions to the field of neuropsychiatric treatments. With a total of two patents to his name, he has made significant strides in the development of innovative medical formulations.

Latest Patents

Amgad Saleh's latest patents focus on a sublingual formulation of riluzole. This formulation is designed for sublingual administration, providing a method for treating neuropsychiatric disorders or symptoms. Additionally, it offers a method for relieving or reducing oral pain through the same sublingual formulation of riluzole. His work in this area highlights the potential for improved patient outcomes in managing neuropsychiatric conditions.

Career Highlights

Throughout his career, Amgad has worked with prominent companies in the pharmaceutical industry, including Biohaven Therapeutics Ltd. and Biohaven Pharmaceutical Holding Company Limited. His experience in these organizations has contributed to his expertise in developing innovative therapeutic solutions.

Collaborations

Amgad has collaborated with notable professionals in the field, including Vladimir Coric and Robert Berman. These partnerships have likely enhanced his research and development efforts, leading to impactful innovations.

Conclusion

Amgad Saleh's work in the development of sublingual formulations for neuropsychiatric treatments showcases his commitment to advancing medical science. His contributions are paving the way for new therapeutic options that can improve the quality of life for patients.